Treating acute nonlymphocytic leukemia.

K. E. Richert-Boe, G. C. Bagby

    Research output: Contribution to journalArticle

    Abstract

    Acute leukemia is no longer an uncommon disease among the middle-aged and elderly. In recent years, treatment programs available for acute nonlymphocytic leukemia have improved dramatically. While remission rates in patients over age 50 are not as high as in younger age groups, combination chemotherapy is effective in a significant number of older patients, and complete remissions can be obtained in 20 to 50%. Recent years have also witnessed much progress in the ability to provide essential supportive therapy during periods of marrow hypoplasia. Because acute leukemia is uniformly fatal if untreated, aggressive therapy should be made available to all these patients, regardless of age.

    Original languageEnglish (US)
    Pages (from-to)50-55
    Number of pages6
    JournalGeriatrics
    Volume33
    Issue number2
    StatePublished - Feb 1978

    Fingerprint

    Acute Myeloid Leukemia
    Leukemia
    Combination Drug Therapy
    Therapeutics
    Age Groups
    Bone Marrow

    ASJC Scopus subject areas

    • Geriatrics and Gerontology

    Cite this

    Richert-Boe, K. E., & Bagby, G. C. (1978). Treating acute nonlymphocytic leukemia. Geriatrics, 33(2), 50-55.

    Treating acute nonlymphocytic leukemia. / Richert-Boe, K. E.; Bagby, G. C.

    In: Geriatrics, Vol. 33, No. 2, 02.1978, p. 50-55.

    Research output: Contribution to journalArticle

    Richert-Boe, KE & Bagby, GC 1978, 'Treating acute nonlymphocytic leukemia.', Geriatrics, vol. 33, no. 2, pp. 50-55.
    Richert-Boe KE, Bagby GC. Treating acute nonlymphocytic leukemia. Geriatrics. 1978 Feb;33(2):50-55.
    Richert-Boe, K. E. ; Bagby, G. C. / Treating acute nonlymphocytic leukemia. In: Geriatrics. 1978 ; Vol. 33, No. 2. pp. 50-55.
    @article{8d3720c01c3e445c8a0d00fb36d79af1,
    title = "Treating acute nonlymphocytic leukemia.",
    abstract = "Acute leukemia is no longer an uncommon disease among the middle-aged and elderly. In recent years, treatment programs available for acute nonlymphocytic leukemia have improved dramatically. While remission rates in patients over age 50 are not as high as in younger age groups, combination chemotherapy is effective in a significant number of older patients, and complete remissions can be obtained in 20 to 50{\%}. Recent years have also witnessed much progress in the ability to provide essential supportive therapy during periods of marrow hypoplasia. Because acute leukemia is uniformly fatal if untreated, aggressive therapy should be made available to all these patients, regardless of age.",
    author = "Richert-Boe, {K. E.} and Bagby, {G. C.}",
    year = "1978",
    month = "2",
    language = "English (US)",
    volume = "33",
    pages = "50--55",
    journal = "Geriatrics",
    issn = "0016-867X",
    publisher = "Advanstar Communications",
    number = "2",

    }

    TY - JOUR

    T1 - Treating acute nonlymphocytic leukemia.

    AU - Richert-Boe, K. E.

    AU - Bagby, G. C.

    PY - 1978/2

    Y1 - 1978/2

    N2 - Acute leukemia is no longer an uncommon disease among the middle-aged and elderly. In recent years, treatment programs available for acute nonlymphocytic leukemia have improved dramatically. While remission rates in patients over age 50 are not as high as in younger age groups, combination chemotherapy is effective in a significant number of older patients, and complete remissions can be obtained in 20 to 50%. Recent years have also witnessed much progress in the ability to provide essential supportive therapy during periods of marrow hypoplasia. Because acute leukemia is uniformly fatal if untreated, aggressive therapy should be made available to all these patients, regardless of age.

    AB - Acute leukemia is no longer an uncommon disease among the middle-aged and elderly. In recent years, treatment programs available for acute nonlymphocytic leukemia have improved dramatically. While remission rates in patients over age 50 are not as high as in younger age groups, combination chemotherapy is effective in a significant number of older patients, and complete remissions can be obtained in 20 to 50%. Recent years have also witnessed much progress in the ability to provide essential supportive therapy during periods of marrow hypoplasia. Because acute leukemia is uniformly fatal if untreated, aggressive therapy should be made available to all these patients, regardless of age.

    UR - http://www.scopus.com/inward/record.url?scp=0017932040&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0017932040&partnerID=8YFLogxK

    M3 - Article

    C2 - 620934

    AN - SCOPUS:0017932040

    VL - 33

    SP - 50

    EP - 55

    JO - Geriatrics

    JF - Geriatrics

    SN - 0016-867X

    IS - 2

    ER -